Research progress on interleukin-6 in lung cancer / 浙江大学学报·医学版
Journal of Zhejiang University. Medical sciences
;
(6): 659-664, 2018.
Article
in Chinese
| WPRIM
| ID: wpr-775264
ABSTRACT
As the core of cellular immunotherapy, T cells are important aspects of research and treatment of lung cancer. IL-6 is a costimulatory signal factor of T cells that is directly targeted by lung cancer stem cells. As a highly expressed cytokine in lung cancer cells, IL-6 plays an important role in variety of biological activities such as tumor occurrence, development, invasion and metastasis. This article reviews the research progress on IL-6 in lung cancer, including cancer development and progression, and the therapeutic sensitivity of lung cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pathology
/
Research
/
Neoplastic Stem Cells
/
T-Lymphocytes
/
Interleukin-6
/
Disease Progression
/
Lung Neoplasms
/
Metabolism
Limits:
Humans
Language:
Chinese
Journal:
Journal of Zhejiang University. Medical sciences
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS